Expanded Access Protocol Using HBOC-201 to Treat Patients With Life Threatening Anemia, for Whom Blood is Not an Option

Trial Profile

Expanded Access Protocol Using HBOC-201 to Treat Patients With Life Threatening Anemia, for Whom Blood is Not an Option

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs Hemoglobin glutamer (Primary)
  • Indications Anaemia
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2016 Status changed from suspended to recruiting.
    • 22 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top